Literature DB >> 15647633

Cognitive behaviour therapy for irritable bowel syndrome.

Jane Hutton1.   

Abstract

The UK Department of Health states that there is suggestive, although not conclusive, evidence for the efficacy of cognitive behavioural therapy (CBT) in irritable bowel syndrome (IBS) and that CBT should be considered as a treatment option for the syndrome. This paper provides a general introduction to CBT, the principles which underlie it and how they can be applied to IBS. The components of CBT for IBS are described in some detail. Guidelines for gastroenterologists are provided on how these principles can be used to inform their practice and the existing outcome data are reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 15647633     DOI: 10.1097/00042737-200501000-00003

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Complementary and alternative medicine for functional gastrointestinal disorders.

Authors:  K Tillisch
Journal:  Gut       Date:  2006-05       Impact factor: 23.059

Review 2.  Psychological approach to managing irritable bowel syndrome.

Authors:  Bu'Hussain Hayee; Ian Forgacs
Journal:  BMJ       Date:  2007-05-26

Review 3.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

Review 4.  Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis.

Authors:  Weidong Wang; Fang Wang; Feng Fan; Ana Cristina Sedas; Jian Wang
Journal:  Int J Behav Med       Date:  2017-04

Review 5.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.